Retraction Note: Antitumor effect and molecular mechanism of fucoidan in NSCLC Authors: Xiaohan Chen, Li Sun, Xiaojuan Wei, Haijun Lu, Ye Tan, Zhanyi Sun, Jinju Jiang Published: 2026 Retraction Note: BMC Complement Med Ther 21: 25 (2021) https://doi.org/10.1186/s12906-020-03191-0 The Editors have retracted this article. After publication, concerns were raised about some of the data in this Article. Specifically, similarities were detected. between Cyclin D1 band in A549 cells (Fig. 2A) and pm-TOR band in A549 cells (Fig. 2B); between Cyclin D1 band in A549 cells (Fig. 2A) and pm-TOR band in A549 cells (Fig. 2B); between the upper part of the A549/Fucoidan 10 mg/ml panel and lower part of the H1650/Fucoidan 10 mg/ml panel; and. between the upper part of the A549/Fucoidan 10 mg/ml panel and lower part of the H1650/Fucoidan 10 mg/ml panel; and. between the lower part of the A549/Fucoidan 16 mg/ml panel and upper part of the H1650/Fucoidan 16 mg/ml panel, between the lower part of the A549/Fucoidan 16 mg/ml panel and upper part of the H1650/Fucoidan 16 mg/ml panel, The Authors have not responded to these concerns. The Editors have therefore lost confidence in the data and conclusions of this article. Authors Xiaohan Chen and Haijun Lu agree with this retraction. Authors Li Sun, Xiaojuan Wei, Ye Tan, Zhanyi Sun, and Jinju Jiang did not respond to correspondence from the Publisher about this retraction.